123 related articles for article (PubMed ID: 36207565)
1. Population Pharmacokinetics and Dosing Simulations of Intravenous Oxycodone for Perioperative Pain Relief in Adult Surgical Patients with Obesity.
Chaw SH; Lo YL; Yeap LL; Haron DEBM; Shariffuddin II
Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):11-21. PubMed ID: 36207565
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and analgesic potency of oxycodone.
Choi BM; Lee YH; An SM; Lee SH; Lee EK; Noh GJ
Br J Clin Pharmacol; 2017 Feb; 83(2):314-325. PubMed ID: 27558774
[TBL] [Abstract][Full Text] [Related]
3. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.
Liukas A; Kuusniemi K; Aantaa R; Virolainen P; Neuvonen M; Neuvonen PJ; Olkkola KT
Drugs Aging; 2011 Jan; 28(1):41-50. PubMed ID: 21174486
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oxycodone after intravenous and subcutaneous administration in Japanese patients with cancer pain.
Kokubun H; Yoshimoto T; Hojo M; Fukumura K; Matoba M
J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):338-50. PubMed ID: 25359452
[TBL] [Abstract][Full Text] [Related]
5. Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?
Charles B; Hardy J; Anderson H; Tapuni A; George R; Norris R
Support Care Cancer; 2014 Feb; 22(2):325-30. PubMed ID: 24077699
[TBL] [Abstract][Full Text] [Related]
6. Hydromorphone population pharmacokinetics in pediatric surgical patients.
Balyan R; Dong M; Pilipenko V; Geisler K; Vinks AA; Chidambaran V
Paediatr Anaesth; 2020 Oct; 30(10):1091-1101. PubMed ID: 32702184
[TBL] [Abstract][Full Text] [Related]
7. Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.
Välitalo P; Kokki M; Ranta VP; Olkkola KT; Hooker AC; Kokki H
Pharm Res; 2017 May; 34(5):1125-1133. PubMed ID: 28205004
[TBL] [Abstract][Full Text] [Related]
8. Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic study.
Saari TI; Ihmsen H; Neuvonen PJ; Olkkola KT; Schwilden H
Br J Anaesth; 2012 Mar; 108(3):491-8. PubMed ID: 22201184
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of oxycodone: Premature neonates to adults.
Morse JD; Sundermann M; Hannam JA; Kokki H; Kokki M; Anderson BJ
Paediatr Anaesth; 2021 Dec; 31(12):1332-1339. PubMed ID: 34469607
[TBL] [Abstract][Full Text] [Related]
10. Oxycodone target concentration dosing for acute pain in children.
Morse JD; Hannam JA; Anderson BJ; Kokki H; Kokki M
Paediatr Anaesth; 2021 Dec; 31(12):1325-1331. PubMed ID: 34469616
[TBL] [Abstract][Full Text] [Related]
11. Analgesic efficacy and pharmacokinetics of epidural oxycodone in pain management after gynaecological laparoscopy-A randomised, double blind, active control, double-dummy clinical comparison with intravenous administration.
Piirainen P; Kokki H; Anderson B; Hannam J; Hautajärvi H; Ranta VP; Kokki M
Br J Clin Pharmacol; 2019 Aug; 85(8):1798-1807. PubMed ID: 31026086
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain.
Hao GT; Zhou HY; Gao HZ; Qu HY; Liang YG; Li YY; Dong RH; Zhang LJ; Wang XF; Liu ZY
Pharmacol Rep; 2014 Feb; 66(1):153-8. PubMed ID: 24905321
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of oxycodone in patients with cancer-related pain.
Komatsu T; Kokubun H; Suzuki A; Takayanagi R; Yamada Y; Matoba M; Yago K
J Pain Palliat Care Pharmacother; 2012 Sep; 26(3):220-5. PubMed ID: 22973910
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
[TBL] [Abstract][Full Text] [Related]
15. A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodone.
Olesen AE; Kristensen K; Staahl C; Kell S; Wong GY; Arendt-Nielsen L; Drewes AM
Clin Pharmacokinet; 2013 Feb; 52(2):125-37. PubMed ID: 23212610
[TBL] [Abstract][Full Text] [Related]
16. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
Singla N; Pong A; Newman K;
Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
[TBL] [Abstract][Full Text] [Related]
17. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer.
Leow KP; Smith MT; Williams B; Cramond T
Clin Pharmacol Ther; 1992 Nov; 52(5):487-95. PubMed ID: 1424423
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy.
Jeleazcov C; Saari TI; Ihmsen H; Mell J; Fröhlich K; Krajinovic L; Fechner J; Schüttler J
Anesthesiology; 2014 Feb; 120(2):378-91. PubMed ID: 23958818
[TBL] [Abstract][Full Text] [Related]
19. Pooled Post Hoc Analysis of Population Pharmacokinetics of Oxycodone and Acetaminophen Following Multiple Oral Doses of Biphasic Immediate-Release/Extended-Release Oxycodone/Acetaminophen Tablets.
Morton T; Franke R; Devarakonda K
Pain Pract; 2016 Jul; 16(6):730-6. PubMed ID: 26218586
[TBL] [Abstract][Full Text] [Related]
20. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
Mandema JW; Kaiko RF; Oshlack B; Reder RF; Stanski DR
Br J Clin Pharmacol; 1996 Dec; 42(6):747-56. PubMed ID: 8971431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
